Fetal Vascular Hemodynamic Changes in Iron Deficiency Anemia

Assiut University

Status: Unknown

Conditions: Iron Deficiency Anemia

Treatments: Drug: Iron Sucrose Solution for Injection

Study type: Observational

Funder types: Other

Identifiers

NCT03883841

DIDA

Details and patient eligibility

About

Iron deficiency anemia is a worldwide medical disorder. So far, it is the most common medical complication in pregnancy specially in developing countries. It is the cause of many adverse effects on mother and fetus and contributes significantly to high maternal mortality. Maternal iron deficiency anemia is frequently associated with premature delivery, low birth weight babies

Enrollment: 60 estimated patients

Sex: Female

Volunteers: No Healthy Volunteers

Inclusion criteria

• Pregnant women with gestational age 28-32 weeks
• singleton pregnancy
• iron deficiency anemia.

Exclusion criteria

• Multiple pregnancy
• antepartum hemorrhage
• major congenital fetal anomalies
• any other type of anemia other than iron deficiency anemia
• any acute or chronic maternal disease other than iron deficiency anemia.

Trial design

60 participants in 2 patient groups

Study group

Description:

patients with iron deficiency anemia

Treatment:

Drug: Iron Sucrose Solution for Injection

control group

Description:

normal pregnant patients